ABEO earnings call for the period ending June 30, 2019.
News & Analysis: Abeona Therapeutics
ABEO earnings call for the period ending March 31, 2019.
ABEO earnings call for the period ending December 31, 2018.
Small market caps. Big opportunities.
A clinical trial update for AB-102 didn't go far enough.
Can these red-hot biotech stocks keep the momentum going?
Positive clinical trial data from a single patient sends shares soaring.
The red-hot gene therapy start-up took a big step towards its first new drug application.
An analyst started coverage at a buy, but there's more that long-term investors should be focused on.
Abeona, Sangamo, and Juno ride the huge wave resulting from Gilead Sciences' acquisition of Kite Pharma.